Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: The Clinical Study on the Treatment of SSc With UTAA91 Injection. [EARLY_Phase 1]
A Phase 1 study evaluating UTAA91 injections for systemic sclerosis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk [Phase 2, Phase 3]
This Clinical Trial Update notes a Phase 2/3 study evaluating whether clopidogrel can prevent the development of systemic sclerosis, with re…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 cell therapy for relapsed/refractory autoimmune diseases is currently recruiting. The study cover…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: TENS in Scleroderma [Phase 1]
A Phase 1 clinical trial update on using a TENS device for patients with systemic sclerosis (scleroderma) and associated gastroparesis, curr…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis [Phase 2]
Phase 2 clinical trial investigating fecal microbiota transplantation to treat constipation and significant bloating in patients with system…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis [NA]
This clinical trial sponsored by The University of Texas Health Science Center, Houston is investigating the pathophysiological mechanisms o…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: PPI Refractory - GERD Mechanisms in Systemic Sclerosis
The trial investigates mechanisms of proton pump inhibitor-refractory gastroesophageal reflux disease in systemic sclerosis and is currently…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis [NA]
A clinical trial update examining pathogenic mechanisms involved in the initiation and progression of systemic sclerosis. It is currently no…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Color Doppler Ultrasonography Evaluation of Abdominal and Peripheral Vasculopathy in Systemic Sclerosis Patients
This clinical trial update describes a study using color Doppler ultrasonography to assess abdominal and peripheral vasculopathy in patients…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Occupational and Environmental Causes of Autoimmune Diseases [NA]
A clinical trial update indicates a study examining occupational and environmental factors in autoimmune diseases has completed. Conditions …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Clinical Study on the Treatment of Systemic Sclerosis With UTAA91 Injection. [EARLY_Phase 1]
An early Phase 1 clinical trial is evaluating UTAA91 injection for Systemic sclerosis conducted by PersonGen BioTherapeutics (Suzhou) Co., L…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating OL-108 in relapsed/refractory autoimmune diseases is currently recruiting, including systemic lupus erythematosus…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update for UCAR T-cell therapy targeting CD19/BCMA in relapse/refractory autoimmune diseases. The study includes seve…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
An early Phase 1 clinical trial is evaluating UTAA91 Injection for relapsed/refractory autoimmune diseases. The study is not yet recruiting …
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases [Phase 1, Phase 2]
Clinical trial update for anti-CD19 CAR T-cell therapy being explored in refractory systemic autoimmune diseases, including systemic lupus e…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease [Phase 2]
A Phase 2 clinical trial evaluating mycophenolate mofetil for systemic sclerosis with subclinical interstitial lung disease is currently rec…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis [Phase 1]
The update outlines a Phase 1 study to assess the safety of intravenous infusion of cultured allogeneic umbilical cord–derived mesenchymal s…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study [Phase 2]
A Phase 2 pilot study evaluating subcutaneous sodium thiosulfate for ectopic calcifications associated with systemic sclerosis and dermatomy…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: MRI for Screening and Monitoring Scleroderma ILD
An update on a clinical trial evaluating MRI for screening and monitoring interstitial lung disease in systemic sclerosis (scleroderma), spo…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial updates describe infusion of mesenchymal stem cells in multiple autoimmune diseases and indicate the …
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis
An ongoing trial is evaluating home-based clinical management of cardiac complications in systemic sclerosis, including pulmonary arterial h…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases [NA]
A clinical trial is planned to evaluate CD7 CAR-T cells for relapsed/refractory autoimmune diseases, specifically systemic sclerosis, with r…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Chester Step Test: is It Effective in Scleroderma Patients? [NA]
This clinical trial update reports a study evaluating whether the Chester Step Test is effective in people with systemic sclerosis (sclerode…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of universal CD19 CAR-T cells (UWD-CD19) with immunosuppressants for refractory auto…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis [Phase 2]
A Phase 2 clinical trial is investigating the efficacy and safety of Telitacicept for systemic sclerosis, focusing on the diffuse cutaneous …